Di Minno, G., and R. Ravasio. “Cost-Effectiveness Analysis of Caplacizumab in the New Standard of Care for Immune Thrombotic Thrombocytopenic Purpura in Italy”. Global and Regional Health Technology Assessment, vol. 8, no. 1, Apr. 2021, pp. 43-52, doi:10.33393/grhta.2021.2191.